J KEVIN BUCHI Insider Trading
Get free email notifications about insider trading for J KEVIN BUCHI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of J KEVIN BUCHI. J KEVIN BUCHI is an Chief Executive Officer in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and a Director in IMPAX LABORATORIES INC ($IPXL) and a Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and a Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and a Director in STEMLINE THERAPEUTICS INC ($STML) and a Director in Alexza Pharmaceuticals Inc. ($ALXA) and a President & CEO in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and a in Dicerna Pharmaceuticals Inc ($DRNA) and a Director in Dicerna Pharmaceuticals Inc ($DRNA) and a Director in Amneal Pharmaceuticals, Inc. ($AMRX).
Companies in which J KEVIN BUCHI is an Insider
Alexza Pharmaceuticals Inc.
Trading Symbol: ALXAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J KEVIN BUCHI: Director
Holdings: 0 shares
Latest Transaction: Jun 21 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Amneal Pharmaceuticals, Inc.
Trading Symbol: AMRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J KEVIN BUCHI: Director
Holdings: 70,085 shares
Latest Transaction: May 07 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOSPECIFICS TECHNOLOGIES CORP
Trading Symbol: BSTCEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J KEVIN BUCHI: Chief Executive Officer
Holdings: 0 shares
Latest Transaction: Oct 25 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dicerna Pharmaceuticals Inc
Trading Symbol: DRNAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J KEVIN BUCHI: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2020
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EPIRUS Biopharmaceuticals, Inc.
Trading Symbol: CRXXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J KEVIN BUCHI: Director
Holdings: 0 shares
Latest Transaction: Jun 08 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Impax Laboratories, LLC
Trading Symbol: IPXLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J KEVIN BUCHI: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 08 2018
$IPXL Market Capitalization: $952.26M
$IPXL Previous Close: $13.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
STEMLINE THERAPEUTICS INC
Trading Symbol: STMLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J KEVIN BUCHI: Director
Holdings: 23,772 shares
Current Value: $147,386
Latest Transaction: Jun 25 2015
$STML Market Capitalization: $118.68M
$STML Previous Close: $6.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TETRALOGIC PHARMACEUTICALS Corp
Trading Symbol: TLOGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J KEVIN BUCHI: President & CEO
Holdings: 330,714 shares
Current Value: $19,843
Latest Transaction: Mar 30 2015
$TLOG Market Capitalization: $1.49M
$TLOG Previous Close: $0.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ZIOPHARM ONCOLOGY INC
Trading Symbol: ZIOPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J KEVIN BUCHI: Director
Holdings: 4,167 shares
Current Value: $27,919
Latest Transaction: May 06 2021
$ZIOP Market Capitalization: $850.83M
$ZIOP Previous Close: $6.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of J KEVIN BUCHI
Sentiment: All, ALXA, AMRX, BSTCE, DRNA, CRXX, IPXL, STML, TLOG, ZIOP
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2021 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | M | 0.00 | 46,218 | 0 | 0 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | A | 0.00 | 35,406 | 0 | 35,406 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Buy | M | 0.00 | 46,218 | 0 | 70,085 | 23.9 K to 70.1 K (+193.65 %) |
May 06 2021 | ZIOP | ZIOPHARM ONCOLOGY ... | BUCHI J KEVIN | Director | Option Exercise | A | 4.31 | 31,250 | 134,688 | 31,250 | |
May 06 2021 | ZIOP | ZIOPHARM ONCOLOGY ... | BUCHI J KEVIN | Director | Grant | A | 0.00 | 4,167 | 0 | 4,167 | 0 to 4.2 K |
Oct 13 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | BUCHI J KEVIN | Director | Option Exercise | A | 2.76 | 146,190 | 403,484 | 146,190 | |
Jun 16 2020 | DRNA | Dicerna Pharmaceut ... | BUCHI J KEVIN | Director | Option Exercise | A | 21.61 | 21,000 | 453,810 | 21,000 |